Anti-inflammatory effects of β-FNA are sex-dependent in a pre-clinical model of LPS-induced inflammation

BACKGROUND: Inflammation is present in neurological and peripheral disorders. Thus, targeting inflammation has emerged as a viable option for treating these disorders. Previous work indicated pretreatment with beta-funaltrexamine (β-FNA), a selective mu-opioid receptor (MOR) antagonist, inhibited in...

Descripción completa

Detalles Bibliográficos
Autores principales: Myers, Stephanie, McCracken, Kelly, Buck, Daniel J., Curtis, J. Thomas, Davis, Randall L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878921/
https://www.ncbi.nlm.nih.gov/pubmed/36698151
http://dx.doi.org/10.1186/s12950-023-00328-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878921/
https://www.ncbi.nlm.nih.gov/pubmed/36698151
http://dx.doi.org/10.1186/s12950-023-00328-z

Ejemplares similares